Erectile dysfunction (ED) is the inability to get and maintain an adequate penile erection for
satisfactory sexual intercourse. Due to its negative impacts on men's life quality and increase …

Background: Multiple systematic reviews explore the effect of phosphodiesterase type 5
(PDE5) inhibitors on erectile dysfunction (ED), with each study addressing specific …

Background Treatment with phosphodiesterase type 5 inhibitors (PDE-5is) is effective in
treating erectile dysfunction (ED). Aim The objective of this study was to determine the effect …

Erectile dysfunction (ED) is a prevalent disease that causes sexual dysfunction in males.
Inflammation‑induced endothelial dysfunction is a fundamental pathophysiological symptom …

Erectile dysfunction (ED) is a prevalent condition affecting men's sexual health, with
oxidative stress (OS) having recently been identified as a significant contributing causative …

Background Combination of different first-line treatments for erectile dysfunction (ED) has
emerged as a promising therapeutic approach. Aim To conduct the first double-blind …

Pelvic malignancies, including prostate, rectal, and bladder cancers, are among the most
frequent malignancies found in the male population. These issues are most effectively and …

目的对真实世界不良事件报告数据进行挖掘, 分析4 种磷酸二酯酶5 (PDE5)
抑制剂的上市后安全性特征. 方法检索美国食品药品监督管理局(FDA) 不良事件报告系统 …

Objective To mine real-world adverse event report data and analyze the post-marketing
safety characteristics of four phosphodiesterase 5 (PDE5) inhibitors. Methods By searching …